Patents by Inventor Katrin Illgen

Katrin Illgen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Tubulysin analogues
    Patent number: 7816377
    Abstract: The invention relates to tubulysin derivatives of general formula (II), said derivatives having a cytostatic effect.
    Type: Grant
    Filed: July 9, 2003
    Date of Patent: October 19, 2010
    Assignee: R&D-Biopharmaceuticals GmbH
    Inventors: Alexander Dömling, Bernd Henkel, Barbara Beck, Katrin Illgen, Sukumar Sakamuri, Sanjay Menon
  • Compounds that inhibit factor Xa activity
    Patent number: 7256194
    Abstract: The present invention relates to compounds of the Formula or a pharmaceutically acceptable salt, solvate, hydrate or formulation thereof. These compounds can be used for the inhibition of Factor Xa and for the treatment and/or prevention of diseases that are mediated by Factor Xa activity.
    Type: Grant
    Filed: February 22, 2002
    Date of Patent: August 14, 2007
    Assignee: Morphochem
    Inventors: Sven Nerdinger, Thilo Fuchs, Katrin Illgen, Robert Eckl
  • Novel compounds that inhibit tryptase activity
    Publication number: 20050245511
    Abstract: The present invention relates to compounds of the Formula or a pharmaceutically acceptable salt, solvate, hydrate or formulation thereof. These compounds can be used for the inhibition of tryptase and for the treatment and/or prevention of diseases that are mediated by tryptase activity.
    Type: Application
    Filed: July 1, 2005
    Publication date: November 3, 2005
    Inventors: Lutz Weber, Thilo Fuchs, Katrin Illgen, Alexander Doemling, Michael Cappi
  • Novel tubulysin analogues
    Publication number: 20050239713
    Abstract: The invention relates to tubulysin derivatives of general formula (II), said derivatives having a cytostatic effect.
    Type: Application
    Filed: July 9, 2003
    Publication date: October 27, 2005
    Applicant: R&D-Biopharmaceuticals Am
    Inventors: Alexander Domling, Bernd Henkel, Barbara Beck, Katrin Illgen, Sukumar Sakamuri, Sanjay Menon
  • Novel compounds that inhibit factor xa activity
    Publication number: 20040082547
    Abstract: The present invention relates to compounds of the Formula 1
    Type: Application
    Filed: November 20, 2003
    Publication date: April 29, 2004
    Inventors: Seven Nerdinger, Thilo Fuchs, Katrin Illgen, Robert Eckl
  • Novel compounds that inhibit tryptase activity
    Publication number: 20020137687
    Abstract: The present invention relates to compounds of the Formula 1
    Type: Application
    Filed: February 20, 2002
    Publication date: September 26, 2002
    Applicant: MORPHOCHEM AG
    Inventors: Lutz Weber, Thilo Fuchs, Katrin Illgen, Alexander Doemling, Michael Cappi